Supprelin 50 MG (65 MCG per 24 HR) Drug Implant

RxCUI: 1294641
RxNorm name: Supprelin 50 MG (65 MCG per 24 HR) Drug Implant
Display name: Supprelin 50 MG (65 MCG per 24 HR) Drug Implant
Full name: Supprelin 50 MG (65 MCG per 24 HR) Drug Implant
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
SUPPRELIN LA	HISTRELIN ACETATE	Endo USA, Inc.	d8fb000e-3cc9-4803-b71d-2cc597661977	2025-09-25	Warnings, Adverse reactions	Exact identifier rxcui: 1294641

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
d8fb000e-3cc9-4803-b71d-2cc597661977	Supprelin 50 MG (65 MCG per 24 HR) Drug Implant	SY	38	These highlights do not include all the information needed to use SUPPRELIN ® LA safely and effectively. See full prescribing information for SUPPRELIN ® LA. SUPPRELIN LA (histrelin acetate) subcutaneous implant Initial U.S. Approval: 1991	20250925
d8fb000e-3cc9-4803-b71d-2cc597661977	Supprelin LA 50 MG (65 MCG per 24HR) Subcutaneous Drug Implant	PSN	38	These highlights do not include all the information needed to use SUPPRELIN ® LA safely and effectively. See full prescribing information for SUPPRELIN ® LA. SUPPRELIN LA (histrelin acetate) subcutaneous implant Initial U.S. Approval: 1991	20250925
d8fb000e-3cc9-4803-b71d-2cc597661977	histrelin acetate 0.00271 MG/HR Drug Implant [Supprelin]	SBD	38	These highlights do not include all the information needed to use SUPPRELIN ® LA safely and effectively. See full prescribing information for SUPPRELIN ® LA. SUPPRELIN LA (histrelin acetate) subcutaneous implant Initial U.S. Approval: 1991	20250925